ArticleCureus2026
A Retrospective Evaluation of Perinatal Outcomes in Pregnant Women With Isolated Gestational Proteinuria.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective This study aimed to examine the role of demographic characteristics and laboratory findings in predicting adverse perinatal outcomes among pregnant women with isolated gestational proteinuria. Methods This single-center retrospective study reviewed records of pregnant women diagnosed with gestational proteinuria at the Umraniye Training and Research Hospital, Istanbul, between January 2010 and December 2023. Women with isolated gestational proteinuria were grouped based on subsequent adverse perinatal outcomes. Demographic characteristics and laboratory parameters at the gestational week of initial proteinuria detection were analyzed. Results A total of 125 women met the inclusion criteria. Among them, 57 (45.6%) experienced no adverse outcomes, whereas 68 (54.4%) developed at least one complication. Outcomes included preeclampsia (n = 20), isolated fetal growth restriction (FGR) (n = 29), small for gestational age (SGA) (n = 3), isolated preterm birth without concomitant pregnancy-related complications (n = 10), and placental abruption (n = 8), with two cases involving both preeclampsia and subsequent placental abruption. Blood urea nitrogen (BUN) level was significantly higher in the preeclampsia group than in the group without adverse perinatal outcomes (p = 0.025). Proteinuria was detected earlier in gestation in the placental abruption group than in the group without adverse perinatal outcomes (p = 0.012). BUN and serum creatinine levels were significantly higher in the placental abruption group than in the group without adverse perinatal outcomes (p = 0.019 and p = 0.009, respectively). Conclusions In women with isolated gestational proteinuria, elevated BUN levels may serve as an early predictor of preeclampsia. Additionally, elevations in BUN and serum creatinine levels may each serve as independent early predictors of placental abruption. Earlier detection of proteinuria appears to be more strongly associated with subsequent placental abruption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.